I am excited to announce our next @ISIMMweb webinar scheduled for Wednesday, May 20 at 11 am ET. Sarah Chiang (@MSKpathology; renowned for major effort in GYN mesenchymal tumors) will present "Cracking the Code of GYN Mesenchymal Tumors." Register here: us02web.zoom.us/webinar/regi…

Very nice resource paper in @Cancer_Cell that enables correlation of cell type specific expression data with survival in #PancreaticCancer. cell.com/cancer-cell/fulltex… Takes TCGA type datasets based on bulk RNA to the next level. Interactive web tool (ctPANDA) allows facile queries.

This is big news indeed and I am glad to see that the proposed new classification will align better with NETs below the diaphragm. A must read for all NET-ologists... Excellent work, @natasharekhtman @AnjaRodenMD and team!

Very good read @JTOonline Moving more towards forgoing the term "carcinoid" and recognizing NET G3 as an entity! @OncoThor #NET #Carcinoid sciencedirect.com/science/ar…

I had the pleasure of presenting our Pitt/UPMC experience in operationalizing AI in pathology at Society of Imaging Informatics in Medicine 2026 Annual Meeting (SIIM2026) alongside @PathPro, Matthew Hanna, and Hooman Rashidi. #DigitalPathology #AIinHealthcare

HER2 In Situ Hybridization: Validation and Implementation of Brightfield Assay in a US Academic Pathology Laboratory journals.lww.com/appliedimmu…

Important Request for Information (RFI) from @NIH “Proposal to Cap the Number of Simultaneous Research Project Grants per Principal Investigator to Support More Researchers and Maximize Scientific Productivity and Innovation” grants.nih.gov/grants/guide/… Some suggested caps & impact:

Today we signed the memorandum of understanding to establish a transatlantic alliance on cancer metastases research between @nyulangone & @karolinskainst. Wonderful to have @USAmbSweden to grace the occasion. A photograph of Team 🇺🇸 in Stockholm. @BarDafna

Dr. Richard Scolyer was a phenomenal example of how pathologists can lead translational cancer research teams. He was vocal about his GBM journey, including being a coauthor on a paper describing an experimental Rx approach to his own case. Rest in peace nature.com/articles/s41591-0…

A total legend and the nicest guy you could ever meet. We will miss you Rich. smh.com.au/culture/celebrity…

I made a smear from a potato and examined it unstained and then under polarized light Starch granules in potato contain amylopectin = Maltese cross birefringence #pfotd @yro854 @tbkwatkins @kriyer68

I'm honored to receive this @StanfordPath award! helps solidify my mantra: #ABT (always be teaching) also, go #GUpath‼️💪🏼🔬

Cytopathology glow-up. Self care during sign out. 😉 #UABcyto

Grateful for the opportunity to present my work at ACLPS 2026 and to share this moment with my mentor, Dr. Anna Merrill. Thank you for your guidance, support, and encouragement throughout this project. #ACLPS2026 #Pathology #Hematopathology #LaboratoryMedicine

A historic moment at #ASCO26: more than 9,000 oncologists rose for three standing ovations as Brian Wolpin, MD, MPH, Director of the Hale Family Center for Pancreatic Cancer Research, presented promising new Phase 3 results for an investigational treatment for metastatic pancreatic cancer. In the trial, daraxonrasib helped patients with previously treated metastatic pancreatic cancer live significantly longer than those who received chemotherapy. While more work remains, these findings offer something powerful: hope for patients and families facing one of the most challenging cancers. As Dr. Wolpin said, “It is exciting to see that we may soon be able to help patients with metastatic pancreatic cancer in ways we haven’t been able to before, improving both survival and quality of life.” Congratulations to the researchers and patients who made this important progress possible. 👏👏👏 Video Courtesy: @asco

Access to all therapies is a human right! Real progress is equitable care across human made boundaries and barriers!

Since you mentioned it, @StanfordPath is hiring: med.stanford.edu/pathology/j… Also seeking #PediPath applicants!

Hope you brought cash! (I find their chicken and cheese better than the cheesesteak, is this considered heresy?)

Cheers, chills, and a standing ovation when RASolute 302 showed unprecedented survival on daraxonrasib for patients with progressive pancreatic cancer Seldom do you sense you’re witnessing a historic moment in cancer care but this feels like ras targeting has arrived #ASCO26

We are hiring! We are looking for a Director of Gastrointestinal Pathology to join our department and lead this outstanding group into the future. Learn more and apply here: facultyrecruiting.northweste…